Coloplast A/S (CLPBY) Earnings Date, Estimates & Call Transcripts $10.75 +0.15 (+1.42%) As of 03/7/2025 03:59 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest Coloplast A/S Latest Earnings SummaryUpcoming Q2 Earnings DateMay. 6Before Market OpensEstimatedActual EPS (Feb. 4) $0.07 Missed By -$0.01 Consensus EPS (Feb. 4) $0.08 Coloplast A/S announced Q1 2025 earnings on February 4, 2025, reporting an EPS of $0.07, which missed analysts' consensus estimates of $0.08 by $0.01. With a trailing EPS of $0.32 and a P/E Ratio of 33.59, Coloplast A/S's earnings are expected to grow 29.03% next year, from $0.31 to $0.40 per share. CLPBY Upcoming EarningsColoplast A/S's next earnings date is estimated for Tuesday, May 6, 2025, based off prior year's reporting schedules. Get Coloplast A/S Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Coloplast A/S and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCLPBY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CLPBY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Coloplast A/S Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$0.31 EPSNext Year EPS Consensus Estimate: $0.40 EPS Remove Ads Coloplast A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)-------2/4/2025Q1 2025$0.08$0.07 -$0.01$0.07--11/5/2024Q4 2024-$0.08+$0.08$0.07-$1.02B8/20/2024Q3 2024-$0.08+$0.08$0.08-$993.49M5/7/2024Q2 2024$0.08$0.08-$0.08-$959.05M2/9/2024Q4 2023$0.08$0.08-$0.08-$953.60M11/9/2023Q4 2023-$0.08+$0.08$0.08-$909.23M8/17/2023Q3 2023-$0.09+$0.09$0.09-$892.53M5/11/2023Q2 2023-$0.08+$0.08$0.08-$873.63M Coloplast A/S Earnings - Frequently Asked Questions When is Coloplast A/S's earnings date? Coloplast A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on CLPBY's earnings history. What guidance has Coloplast A/S issued on next quarter's earnings? Coloplast A/S updated its FY 2025 earnings guidance on Tuesday, February, 4th. The company issued revenue guidance of $4.2 billion-$4.3 billion. Did Coloplast A/S beat their earnings estimates last quarter? In the previous quarter, Coloplast A/S (OTCMKTS:CLPBY) missed the analysts' consensus estimate of $0.08 by $0.01 with a reported earnings per share (EPS) of $0.07. Learn more on analysts' earnings estimate vs. CLPBY's actual earnings. How much revenue does Coloplast A/S generate each year? Coloplast A/S (OTCMKTS:CLPBY) has a recorded annual revenue of $3.93 billion. How much profit does Coloplast A/S generate each year? Coloplast A/S (OTCMKTS:CLPBY) has a recorded net income of $734.56 million. CLPBY has generated $0.32 earnings per share over the last four quarters. What is Coloplast A/S's price-to-earnings ratio? Coloplast A/S (OTCMKTS:CLPBY) has a trailing price-to-earnings ratio of 33.59 and a forward price-to-earnings ratio of 34.68. The price/earnings-to-growth ratio is 3.08. What is Coloplast A/S's EPS forecast for next year? Coloplast A/S's earnings are expected to grow from $0.31 per share to $0.40 per share in the next year, which is a 29.03% increase. More Earnings Resources from MarketBeat Related Companies ISRG Earnings Results EW Earnings Results STE Earnings Results ZBH Earnings Results ALGN Earnings Results MSA Earnings Results ENOV Earnings Results CDRE Earnings Results ESTA Earnings Results AVNS Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of EarningsThe Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance? Remove Ads This page (OTCMKTS:CLPBY) was last updated on 3/9/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coloplast A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Coloplast A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLPBY Stock Alerts